you are here: HomeNewsIndia

Record 75,760 COVID-19 cases in single day, India's virus tally crosses 33-lakh mark

A record 75,760 infections were added in a day, taking the total coronavirus caseload to 33,10,234. The death toll climbed to 60,472 with 1,023 fatalities being reported in 24 hours, the data updated at 8 am showed.

August 27, 2020 / 10:27 AM IST

Registering over 75,000 COVID-19 cases for the first time in a span of 24 hours, India's virus tally sprinted past 33 lakh on Thursday, while the number of recoveries crossed the 25 lakh mark, according to the Union Health Ministry data.

A record 75,760 infections were added in a day, taking the total coronavirus caseload to 33,10,234. The death toll climbed to 60,472 with 1,023 fatalities being reported in 24 hours, the data updated at 8 am showed.

With a total of 25,23,771 patients having  recuperated so far, the recovery rate was recorded at 76.24 percent while the COVID-19 case fatality rate has declined to 1.83 percent.

There are 7,25,991 active cases of coronavirus infection in the country which comprises 21.93  percent of the total caseload, the data stated.

India's COVID-19 tally had crossed the 20-lakh mark on August 7 and went past 30 lakh on August 23.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
According to the ICMR, a cumulative total of 3,85,76,510 samples have been tested up to August 26 with 9,24,998 samples being tested on Wednesday.
PTI
first published: Aug 27, 2020 10:21 am

stay updated

Get Daily News on your Browser
Sections